Atlas Trials

Safety, Toleration and Pharmacokinetics of Single Intravenous Doses of Peptide YY in Overweight Adults

Clinical trial NCT00331175 · COMPLETED

Trial details

NCT number
NCT00331175
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Obesity
Start date
2006-07-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.